|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.250 USD | +2.27% |
|
-.--% | +4.65% |
| 06-10 | Magnora Unveils NOK50 Million Share Buyback Program | MT |
| 06-08 | Major European indices flat - Zealand Pharma plunges | FW |
Company Valuation: Magnora ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 121.5 | 143.7 | 214 | 156.1 | 124.9 | 170.6 | - | - |
| Change | - | 18.31% | 48.86% | -27.05% | -19.96% | 36.51% | - | - |
| Enterprise Value (EV) 1 | 110.6 | 134.3 | 181.2 | 133.5 | 107.9 | 147.7 | 123 | 93 |
| Change | - | 21.44% | 34.91% | -26.33% | -19.21% | 36.87% | -16.73% | -24.36% |
| P/E | -17.3x | 108x | 12.1x | 3.08x | 130x | -21x | 6.59x | 6.02x |
| PBR | 6.3x | 3.52x | 4.31x | 4.52x | 3.16x | 4.05x | 2.53x | 1.64x |
| PEG | - | -1x | 0x | 0x | -1.3x | 0x | -0x | 0.63x |
| Capitalization / Revenue | 71.2x | 16x | 8.3x | 4.87x | 9.8x | 35.1x | 3.96x | 4.5x |
| EV / Revenue | 64.8x | 14.9x | 7.03x | 4.16x | 8.46x | 30.4x | 2.85x | 2.45x |
| EV / EBITDA | -25.6x | 129x | 11.5x | 6.26x | 187x | -21.9x | 9.7x | 3.61x |
| EV / EBIT | -16.4x | 203x | 10.9x | 5.34x | -343x | -20.2x | 5.24x | 3.61x |
| EV / FCF | -15.6x | -7.71x | -45.6x | 6.08x | 24.2x | 13x | 3.7x | 5.99x |
| FCF Yield | -6.43% | -13% | -2.19% | 16.5% | 4.14% | 7.69% | 27.1% | 16.7% |
| Dividend per Share 2 | - | - | - | 0.4054 | - | - | - | - |
| Rate of return | - | - | - | 16.6% | - | - | - | - |
| EPS 2 | -0.1236 | 0.0199 | 0.2694 | 0.791 | 0.015 | -0.1125 | 0.358 | 0.392 |
| Distribution rate | - | - | - | 51.2% | - | - | - | - |
| Net sales 1 | 1.707 | 9.011 | 25.79 | 32.08 | 12.75 | 4.864 | 43.09 | 37.93 |
| EBITDA 1 | -4.324 | 1.039 | 15.82 | 21.31 | 0.5759 | -6.738 | 12.67 | 25.79 |
| EBIT 1 | -6.75 | 0.6627 | 16.63 | 25.02 | -0.3142 | -7.305 | 23.45 | 25.79 |
| Net income 1 | -7.054 | 1.236 | 18.13 | 52.76 | 0.9948 | -3.682 | 11.56 | - |
| Net Debt 1 | -10.88 | -9.408 | -32.74 | -22.58 | -17.07 | -22.91 | -47.61 | -77.56 |
| Reference price 2 | 2.132 | 2.152 | 3.254 | 2.440 | 1.955 | 2.360 | 2.360 | 2.360 |
| Nbr of stocks (in thousands) | 56,997 | 66,801 | 65,752 | 63,979 | 63,914 | 72,255 | - | - |
| Announcement Date | 2/15/22 | 2/14/23 | 2/29/24 | 2/27/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.57x | 2.68x | 17.72x | 1.28% | 145B | ||
| 13.95x | 1.79x | 9.85x | 1.71% | 30.77B | ||
| 12.24x | 0.76x | 8.98x | 3.86% | 12.25B | ||
| -16.33x | 0.63x | 8.13x | -.--% | 4.16B | ||
| 15.75x | 0.69x | 8.6x | 3.58% | 3.25B | ||
| 14.83x | - | - | 0.73% | 2.27B | ||
| 22.24x | - | - | - | 2.18B | ||
| -129.73x | 0.48x | 29.04x | -.--% | 1.87B | ||
| 33.59x | 0.88x | 5.8x | -.--% | 940M | ||
| Average | 0.12x | 1.13x | 12.59x | 1.39% | 22.47B | |
| Weighted average by Cap. | 26.85x | 2.32x | 15.65x | 1.49% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MGN Stock
- SVMRF Stock
- Valuation Magnora ASA
Select your edition
All financial news and data tailored to specific country editions
















